Medicine & Health

Trailblazer Victoria Fraser, MD, head of the Department of Medicine, the medical school’s largest department, advocates for equity in academic medicine and addresses structural barriers that limit the careers of women and members of other underrepresented groups.

Studying mice, Washington University School of Medicine researchers have discovered that roseolovirus can trigger autoimmunity in a previously unknown way: by disrupting the process by which immune cells learn to avoid targeting their own body’s cells and tissues.

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine researchers.

Antibodies elicited by COVID-19 vaccination become steadily more powerful for at least six months after vaccination, according to a study by researchers at Washington University School of Medicine that involved the Pfizer-BioNTech COVID-19 vaccine.

Medical trailblazer Victoria Fraser, MD, focuses on creating equity in academic medicine.

Health-care workers at the Washington University School of Medicine have contributed greatly to regional and world health during the pandemic, and we owe them so much appreciation.

Researchers at Washington University School of Medicine have shown, in mice, that a new class of compounds they developed can improve several aspects of metabolic syndrome. Such conditions often lead to cardiovascular disease, the leading cause of death worldwide.

Five researchers from the School of Medicine and one from the McKelvey School of Engineering have been named senior members of the National Academy of Inventors.

Washington University School of Medicine is participating in a nationwide phase 2 clinical trial to evaluate whether an investigational omicron-specific booster of the Moderna COVID-19 vaccine is safe and capable of eliciting a strong immune response.

In two recent studies, researchers at Washington University School of Medicine found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.